Safety, Tolerability and Pharmacokinetics of the eNAMPT-Neutralizing ALT-100 Mab in Healthy Volunteers.

Single intravenous ALT-100 mAb doses are well tolerated in healthy participants with dose proportional PK and elimination half-life.

Authors

Susanna Mantovani (ORCID: https://orcid.org/0000-0001-7046-6541)
Thomas M. Polasek (ORCID: https://orcid.org/0000-0003-1008-5223)
Sara M. Camp
Joe G. N. Garcia (ORCID: https://orcid.org/0000-0002-6934-0420)
Stan Miele

Institutions

Scripps Research Institute (US)
International Drug Development (FR)

Publication Details

Journal: PubMed
Published: 2024-09-01
Primary Topic: Erythropoietin and Anemia Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety, Tolerability and Pharmacokinetics of the eNAMPT-Neutralizing ALT-100 Mab in Healthy Volunteers.

Susanna Mantovani, Thomas M. Polasek, Sara M. Camp, Joe G. N. Garcia et al.

Sep 1, 2024

1 links

PubMed

Erythropoietin and Anemia Treatment

article

Safety, Tolerability and Pharmacokinetics of the eNAMPT-Neutralizing ALT-100 Mab in Healthy Volunteers.

Susanna Mantovani, Thomas M. Polasek, Sara M. Camp, Joe G. N. Garcia, Stan Miele

September 1, 2024article en

Abstract

Single intravenous ALT-100 mAb doses are well tolerated in healthy participants with dose proportional PK and elimination half-life.

PubMedVol. 3(3)

Scripps Research Institute (US), International Drug Development (FR)

Openalex Percentile: Top 54%

Erythropoietin and Anemia Treatment

Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety, Tolerability and Pharmacokinetics of the eNAMPT-Neutralizing ALT-100 Mab in Healthy Volunteers. — Susanna Mantovani, Thomas M. Polasek, et al. · PubMed (2024) | TGRS Research Map | TGRS